RE:Great newsMy favorite paragraph: "We are thrilled to welcome Dr. Greenberg to the Board as we establish Braxia as the leader in setting the standard of care in mental health for depression and as we grow our clinical platform to support development of novel ketamine and psychedelic based medicines in Canada and the United States," said Dr. Roger McIntyre, CEO, Braxia Scientific. "Dr. Greenberg's extensive experience and network within the North American and international healthcare community, in particular in the areas of mental health and concussion and with professional athletes, among others, will be a significant advantage as we continue to develop and implement breakthrough Ketamine treatments and protocols that will result in improved outcomes for patients that come to our clinics."
We're getting ready to rock and roll.